Zobrazeno 1 - 10
of 17
pro vyhledávání: '"ZHENGGANG ZHAO"'
Autor:
Xindan Zhang, Zhenggang Zhao, Xuepeng Wang, Shiwei Zhang, Zilong Zhao, Wenbin Feng, Lijun Xu, Junhua Nie, Hong Li, Jia Liu, Gengmiao Xiao, Yu Zhang, Haomiao Li, Ming Lu, Jialuo Mai, Sujin Zhou, Allan Z. Zhao, Fanghong Li
Publikováno v:
Cell Death and Disease, Vol 15, Iss 5, Pp 1-15 (2024)
Abstract Osteosarcoma is a malignant bone tumor that primarily inflicts the youth. It often metastasizes to the lungs after chemotherapy failure, which eventually shortens patients’ lives. Thus, there is a dire clinical need to develop a novel ther
Externí odkaz:
https://doaj.org/article/9bfbff5e24ae40dc8bd2264cf10b9226
Autor:
Sujin Zhou, Xianan Zhao, Shiwei Zhang, Xue Tian, Xuepeng Wang, Yunping Mu, Fanghong Li, Allan Z. Zhao, Zhenggang Zhao
Publikováno v:
BMC Medical Genomics, Vol 16, Iss 1, Pp 1-13 (2023)
Abstract Background Glioma cells have increased intake and metabolism of methionine, which can be monitored with 11 C-L-methionine. However, a short half-life of 11 C (~ 20 min) limits its application in clinical practice. It is necessary to develop
Externí odkaz:
https://doaj.org/article/c72a1c2fded34dc0a62f3bb4667ef9ad
Autor:
Sujin Zhou, Shiwei Zhang, Kexin Zheng, Zixuan Li, Enyu Hu, Yunping Mu, Jialuo Mai, Allan Zhao, Zhenggang Zhao, Fanghong Li
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background Although immune checkpoint inhibitor (ICI)-based therapy is advantageous for patients with advanced melanoma, resistance and relapse are frequent. Thus, it is crucial to identify effective drug combinations and develop new therapies for th
Externí odkaz:
https://doaj.org/article/bd576ee293b04182a0d63157c5fc8072
Autor:
Ping Mao, Wenbin Feng, Zongmeng Zhang, Changhao Huang, Sujin Zhou, Zhenggang Zhao, Yunping Mu, April Yuanyi Zhao, Lina Wang, Fanghong Li, Allan Z. Zhao
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 11, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/0ed38626e2274d5a86218838cf1c625b
Autor:
Zongmeng Zhang, Jinlin Du, Hui Shi, Shuai Wang, Yunjing Yan, Qihua Xu, Sujin Zhou, Zhenggang Zhao, Yunping Mu, Chaonan Qian, Allan Zijian Zhao, Sumei Cao, Fanghong Li
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-16 (2022)
Abstract Background Adiponectin is an adipocyte-secreted cytokine that enhances insulin sensitivity and attenuates inflammation. Although circulating adiponectin level is often inversely associated with several malignancies, its role in the developme
Externí odkaz:
https://doaj.org/article/19e90356079f484183d1585e9866c378
Autor:
Xiaoming Bai, Jiaofang Shao, Sujin Zhou, Zhenggang Zhao, Fanghong Li, Rong Xiang, Allan Z. Zhao, Jinshun Pan
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-13 (2019)
Abstract Background Non small cell lung cancer (NSCLC) is one of the most common cancers in the world. DHA is known to be capable of suppressing NSCLC cell proliferation and metastasis. However, the mechanisms by which DHA exhibits its antitumor effe
Externí odkaz:
https://doaj.org/article/df90f6fa899441fc90c49bbb67bead30
Autor:
Qihua Xu, Zongmeng Zhang, Minyi Tang, Chaofeng Xing, Hansi Chen, Kexin Zheng, Zhenggang Zhao, Sujin Zhou, Allan Zijian Zhao, Fanghong Li, Yunping Mu
Publikováno v:
Free Radical Biology and Medicine. 201:14-25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8bc6d2f537258ac98b3f6c18f64258b
https://doi.org/10.1016/j.freeradbiomed.2023.03.005
https://doi.org/10.1016/j.freeradbiomed.2023.03.005
Autor:
Longming Liang, Hansi Chen, Ping Mao, Yuyu Li, Lijun Xu, Yujie He, Yunping Mu, Allan Z. Zhao, Sujin Zhou, Zhenggang Zhao, Fanghong Li
Publikováno v:
Investigational New Drugs. 40:875-883
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that frequently develops resistance to chemotherapy. A new approach to treating TNBC is required to improve patient survival. Phosphodiesterase-4 (PDE4) is an enzyme that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3a184354683c387779578c3c8a521da
https://doi.org/10.1007/s10637-022-01258-y
https://doi.org/10.1007/s10637-022-01258-y
Autor:
Zongmeng Zhang, Jinlin Du, Qihua Xu, Yuyu Li, Sujin Zhou, Zhenggang Zhao, Yunping Mu, Allan Z. Zhao, Su-Mei Cao, Fanghong Li
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 6003
Background Nasopharyngeal carcinoma (NPC) is a malignant tumor with a high risk of local invasion and early distant metastasis. Resistin is an inflammatory cytokine predominantly produced from the immunocytes in humans. Accumulating evidence suggeste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0100e80c391e749384f957fefe8f94d9
Autor:
Zongmeng Zhang, Jinlin Du, Qihua Xu, Chaofeng Xing, Yuyu Li, Sujin Zhou, Zhenggang Zhao, Yunping Mu, Zijian (Allan) Zhao, Sumei Cao, Fanghong Li
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 12729
Adiponectin is an adipocytokine with anti-inflammatory and anticancer properties. Our previous study has shown that blood adiponectin levels were inversely correlated to the risk of nasopharyngeal carcinoma (NPC), and that adiponectin could directly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::601551fea34680eb0da2aba9b54c6e71
https://pubmed.ncbi.nlm.nih.gov/36361525
https://pubmed.ncbi.nlm.nih.gov/36361525